ArticleEndocrine connections2026
Differential somatostatin sensitivity of corticotropic and somatotropic responses following amino acid infusion.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAmino acids stimulate pituitary hormone secretion, but whether somatostatin-sensitive pathways differentially regulate activation of the corticotropic and somatotropic axes during amino acid infusion remains unclear. We investigated whether somatostatin signalling constrains growth hormone secretion following amino acid infusion differently from ACTH and cortisol responses in humans.
methodsWe conducted a randomized, within-subject crossover study in 15 healthy adults with three morning visits: amino acid infusion plus saline, somatostatin analogue infusion plus saline, and combined amino acid plus somatostatin analogue infusion. Vamin, an amino acid mixture, was infused at 331 mg·kg-1·h-1 from 0 to 45 min, and octreotide, a somatostatin analogue, was infused at 200 ng·kg-1·min-1 from -75 to 165 min; blood was sampled from -75 to 300 min. Post hoc exploratory outcomes included baseline-subtracted area-under-the-curve measures for cortisol, ACTH, and growth hormone, analysed using repeated-measures mixed-effects models.
resultsFollowing amino acid infusion, ACTH and cortisol showed rapid responses, peaking around 45 min, whereas growth hormone increased gradually and peaked around 120 min. Compared with somatostatin analogue alone, amino acid infusion increased peak concentrations and baseline-subtracted exposures for cortisol, ACTH, and growth hormone. Co-infusion with somatostatin analogue substantially reduced ACTH and cortisol responses but almost completely abolished growth hormone secretion.
conclusionCorticotropic and somatotropic responses were observed following intravenous amino acid infusion in humans, with markedly different somatostatin sensitivity. Growth hormone secretion was almost completely suppressed by somatostatin analogue administration, whereas ACTH and cortisol responses remained partly preserved, suggesting that HPA axis activation can partly escape somatostatin inhibition. SIGNIFICANCE STATEMENT: Amino acids are commonly viewed as nutritional substrates, but they can also act as endocrine stimuli. In this study, intravenous amino acid infusion was followed by activation of both the corticotropic and somatotropic axes in healthy adults, producing rapid ACTH-cortisol responses and a delayed growth hormone response. The findings show that these responses differ markedly in their sensitivity to somatostatin signalling: growth hormone secretion was almost completely suppressed by somatostatin analogue administration, whereas ACTH and cortisol responses remained partly preserved. These findings provide physiological insights into how corticotropic and somatotropic responses following amino acid infusion differ in their sensitivity to octreotide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.